Cargando…

Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury

BACKGROUND: The optimal time to initiate renal replacement therapy (RRT) in intensive care unit (ICU) patients with acute kidney injury (AKI) is unclear. We examined the impact of early RRT on long-term mortality, risk of chronic kidney disease (CKD), and end-stage renal disease (ESRD). METHODS: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Christiansen, Søren, Christensen, Steffen, Pedersen, Lars, Gammelager, Henrik, Layton, J. Bradley, Brookhart, M. Alan, Christiansen, Christian Fynbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745999/
https://www.ncbi.nlm.nih.gov/pubmed/29282093
http://dx.doi.org/10.1186/s13054-017-1903-y
_version_ 1783289022625349632
author Christiansen, Søren
Christensen, Steffen
Pedersen, Lars
Gammelager, Henrik
Layton, J. Bradley
Brookhart, M. Alan
Christiansen, Christian Fynbo
author_facet Christiansen, Søren
Christensen, Steffen
Pedersen, Lars
Gammelager, Henrik
Layton, J. Bradley
Brookhart, M. Alan
Christiansen, Christian Fynbo
author_sort Christiansen, Søren
collection PubMed
description BACKGROUND: The optimal time to initiate renal replacement therapy (RRT) in intensive care unit (ICU) patients with acute kidney injury (AKI) is unclear. We examined the impact of early RRT on long-term mortality, risk of chronic kidney disease (CKD), and end-stage renal disease (ESRD). METHODS: This cohort study included all adult patients treated with continuous RRT in the ICU at Aarhus University Hospital, Skejby, Denmark (2005–2015). Data were obtained from a clinical information system and population-based registries. Early treatment was defined as RRT initiation at AKI stage 2 or below, and late treatment was defined as RRT initiation at AKI stage 3. Inverse probability of treatment (IPT) weights were computed from propensity scores. The IPT-weighted cumulative risk of CKD (estimated glomerular filtration rate < 60 ml/minute/1.73 m(2)), ESRD, and mortality was estimated and compared using IPT-weighted Cox regression. RESULTS: The mortality, CKD, and ESRD analyses included 1213, 303, and 617 patients, respectively. The 90-day mortality in the early RRT group was 53.6% compared with 46.0% in the late RRT group (HR 1.24, 95% CI 1.03–1.48). The 90-day to 5-year mortality was 37.7% and 41.5% in the early and late RRT groups, respectively (HR 0.95, 95% CI 0.70–1.29). The 5-year risk of CKD was 35.9% in the early RRT group and 44.9% in the late RRT group (HR 0.74, 95% CI 0.46–1.18). The 5-year risk of ESRD was 13.3% in the early RRT group and 16.7% in the late RRT group (HR 0.79, 95% CI 0.47–1.32). CONCLUSIONS: Early initiation was associated with increased 90-day mortality. In patients surviving to day 90, early initiation was not associated with a major impact on long-term mortality or risk of CKD and ESRD. Despite potential residual confounding due to the observational design, our findings do not support that early RRT initiation is superior to late initiation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1903-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5745999
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57459992018-01-03 Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury Christiansen, Søren Christensen, Steffen Pedersen, Lars Gammelager, Henrik Layton, J. Bradley Brookhart, M. Alan Christiansen, Christian Fynbo Crit Care Research BACKGROUND: The optimal time to initiate renal replacement therapy (RRT) in intensive care unit (ICU) patients with acute kidney injury (AKI) is unclear. We examined the impact of early RRT on long-term mortality, risk of chronic kidney disease (CKD), and end-stage renal disease (ESRD). METHODS: This cohort study included all adult patients treated with continuous RRT in the ICU at Aarhus University Hospital, Skejby, Denmark (2005–2015). Data were obtained from a clinical information system and population-based registries. Early treatment was defined as RRT initiation at AKI stage 2 or below, and late treatment was defined as RRT initiation at AKI stage 3. Inverse probability of treatment (IPT) weights were computed from propensity scores. The IPT-weighted cumulative risk of CKD (estimated glomerular filtration rate < 60 ml/minute/1.73 m(2)), ESRD, and mortality was estimated and compared using IPT-weighted Cox regression. RESULTS: The mortality, CKD, and ESRD analyses included 1213, 303, and 617 patients, respectively. The 90-day mortality in the early RRT group was 53.6% compared with 46.0% in the late RRT group (HR 1.24, 95% CI 1.03–1.48). The 90-day to 5-year mortality was 37.7% and 41.5% in the early and late RRT groups, respectively (HR 0.95, 95% CI 0.70–1.29). The 5-year risk of CKD was 35.9% in the early RRT group and 44.9% in the late RRT group (HR 0.74, 95% CI 0.46–1.18). The 5-year risk of ESRD was 13.3% in the early RRT group and 16.7% in the late RRT group (HR 0.79, 95% CI 0.47–1.32). CONCLUSIONS: Early initiation was associated with increased 90-day mortality. In patients surviving to day 90, early initiation was not associated with a major impact on long-term mortality or risk of CKD and ESRD. Despite potential residual confounding due to the observational design, our findings do not support that early RRT initiation is superior to late initiation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1903-y) contains supplementary material, which is available to authorized users. BioMed Central 2017-12-28 /pmc/articles/PMC5745999/ /pubmed/29282093 http://dx.doi.org/10.1186/s13054-017-1903-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Christiansen, Søren
Christensen, Steffen
Pedersen, Lars
Gammelager, Henrik
Layton, J. Bradley
Brookhart, M. Alan
Christiansen, Christian Fynbo
Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury
title Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury
title_full Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury
title_fullStr Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury
title_full_unstemmed Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury
title_short Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury
title_sort timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745999/
https://www.ncbi.nlm.nih.gov/pubmed/29282093
http://dx.doi.org/10.1186/s13054-017-1903-y
work_keys_str_mv AT christiansensøren timingofrenalreplacementtherapyandlongtermriskofchronickidneydiseaseanddeathinintensivecarepatientswithacutekidneyinjury
AT christensensteffen timingofrenalreplacementtherapyandlongtermriskofchronickidneydiseaseanddeathinintensivecarepatientswithacutekidneyinjury
AT pedersenlars timingofrenalreplacementtherapyandlongtermriskofchronickidneydiseaseanddeathinintensivecarepatientswithacutekidneyinjury
AT gammelagerhenrik timingofrenalreplacementtherapyandlongtermriskofchronickidneydiseaseanddeathinintensivecarepatientswithacutekidneyinjury
AT laytonjbradley timingofrenalreplacementtherapyandlongtermriskofchronickidneydiseaseanddeathinintensivecarepatientswithacutekidneyinjury
AT brookhartmalan timingofrenalreplacementtherapyandlongtermriskofchronickidneydiseaseanddeathinintensivecarepatientswithacutekidneyinjury
AT christiansenchristianfynbo timingofrenalreplacementtherapyandlongtermriskofchronickidneydiseaseanddeathinintensivecarepatientswithacutekidneyinjury